Cite Filings / IRLA / 0001140361-23-057682
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SC 13G

Amended Statement of Ownership

IRulya Therapeutics Inc. · Filed 2023-12-15 · Acc 0001140361-23-057682

Documents 1

  • SC 13G Amended Statement of Ownership , ef20016690_sc13g.htm

Around this filing

  • 2024-02-12 SC 13G Amended Statement of Ownership
  • 2023-12-22 8-K Agreement ended
  • 2023-12-15 SC 13G Amended Statement of Ownership
  • 2023-12-14 4 Director bought 67,881 shares at an average $1.02 ($69,233)
  • 2023-12-08 8-K Delisting notice
  • 2023-07-17 SC 13G Amended Statement of Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G/A · Squadron Master Fund LP 8.8%
  2. 2026-11-16 SCHEDULE 13G/A · Ikarian Capital, LLC 2.3%
  3. 2026-11-16 SCHEDULE 13G/A · BALYASNY ASSET MANAGEMENT L.P. 9.99%
  4. 2026-11-16 SCHEDULE 13G/A · SilverArc Capital Management, LLC 7.9%
  5. 2026-11-13 SCHEDULE 13G · SilverArc Capital Management, LLC 7.9%
Loading ef20016690_sc13g.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…